AMINO-TERMINAL PROTEIN-PROTEIN INTERACTION MOTIF (POZ-DOMAIN) IS RESPONSIBLE FOR ACTIVITIES OF THE PROMYELOCYTIC LEUKEMIA ZINC-FINGER RETINOIC ACID RECEPTOR-ALPHA FUSION PROTEIN

Promyelocytic leukemia zinc finger-retinoic acid receptor alpha (PLZF- RAR alpha), a fusion receptor generated as a result of a variant t(11; 17) chromosomal translocation that occurs in a small subset of acute p romyelocytic leukemia (APL) patients, has been shown to display a domi nant-negative effect against the wild-type RAR alpha/retinoid X recept or alpha (RXR alpha). We now show that its N-terminal region (called t he POZ-domain), which mediates protein-protein interaction as well as specific nuclear localization of the wild-type PLZF and chimeric PLZF- RAR alpha proteins, is primarily responsible for this activity, To fur ther investigate the mechanisms of PLZF-RAR alpha action, we have also studied its ligand-receptor, protein-protein, and protein-DNA interac tion properties and compared them with those of the promyelocytic leuk emia gene (PML)-RAR alpha, which is expressed in the majority of APLs as a result of t(15;17) translocation, PLZF-RAR alpha and PML-RAR alph a have essentially the same ligand-binding affinities and can bind in vitro to retinoic acid response elements (RAREs) as homodimers or hete rodimers with RXR alpha. PLZF-RAR alpha homodimerization and heterodim erization with RXR alpha were primarily mediated by the POZ-domain and RAR alpha sequence, respectively, Despite having identical RAR alpha sequences, PLZF-RAR alpha and PML-RAR alpha homodimers recognized with different affinities distinct RAREs. Furthermore, PLZF-RAR alpha coul d heterodimerize in vitro with the wild-type PLZF, suggesting that it may play a role in leukemogenesis by antagonizing actions of not only the retinoid receptors hut also the wild-type PLZF and possibly other POZ-domain-containing regulators. These different protein-protein inte ractions and the target gene specificities of PLZF-RAR alpha and PML-R AR alpha may underlie, at least in part, the apparent resistance of AP L with t(11;17) to differentiation effects of all-trans-retinoic acid.